Literature DB >> 33763063

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game.

Jean-Louis Palgen1,2, Yanis Feraoun1, Gaëlle Dzangué-Tchoupou1, Candie Joly1, Frédéric Martinon1, Roger Le Grand1, Anne-Sophie Beignon1.   

Abstract

Most vaccines require multiple doses to induce long-lasting protective immunity in a high frequency of vaccines, and to ensure strong both individual and herd immunity. Repetitive immunogenic stimulations not only increase the intensity and durability of adaptive immunity, but also influence its quality. Several vaccine parameters are known to influence adaptive immune responses, including notably the number of immunizations, the delay between them, and the delivery sequence of different recombinant vaccine vectors. Furthermore, the initial effector innate immune response is key to activate and modulate B and T cell responses. Optimization of homologous and heterologous prime/boost vaccination strategies requires a thorough understanding of how vaccination history affects memory B and T cell characteristics. This requires deeper knowledge of how innate cells respond to multiple vaccine encounters. Here, we review how innate cells, more particularly those of the myeloid lineage, sense and respond differently to a 1st and a 2nd vaccine dose, both in an extrinsic and intrinsic manner. On one hand, the presence of primary specific antibodies and memory T cells, whose critical properties change with time after priming, provides a distinct environment for innate cells at the time of re-vaccination. On the other hand, innate cells themselves can exert enhanced intrinsic antimicrobial functions, long after initial stimulation, which is referred to as trained immunity. We discuss the potential of trained innate cells to be game-changers in prime/boost vaccine strategies. Their increased functionality in antigen uptake, antigen presentation, migration, and as cytokine producers, could indeed improve the restimulation of primary memory B and T cells and their differentiation into potent secondary memory cells in response to the boost. A better understanding of trained immunity mechanisms will be highly valuable for harnessing the full potential of trained innate cells, to optimize immunization strategies.
Copyright © 2021 Palgen, Feraoun, Dzangué-Tchoupou, Joly, Martinon, Le Grand and Beignon.

Entities:  

Keywords:  immunization; inflammation; innate immune memory; prime/boost vaccine strategies; trained immunity; vaccine

Mesh:

Substances:

Year:  2021        PMID: 33763063      PMCID: PMC7982481          DOI: 10.3389/fimmu.2021.612747

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  104 in total

Review 1.  Prime-boost immunisation strategies for tuberculosis.

Authors:  Helen McShane; Adrian Hill
Journal:  Microbes Infect       Date:  2005-04-15       Impact factor: 2.700

Review 2.  Innate immune memory of tissue-resident macrophages and trained innate immunity: Re-vamping vaccine concept and strategies.

Authors:  Zhou Xing; Sam Afkhami; Jegarubee Bavananthasivam; Dominik K Fritz; Michael R D'Agostino; Maryam Vaseghi-Shanjani; Yushi Yao; Mangalakumari Jeyanathan
Journal:  J Leukoc Biol       Date:  2020-03-03       Impact factor: 4.962

3.  NK cell immune responses differ after prime and boost vaccination.

Authors:  Jean-Louis Palgen; Nicolas Tchitchek; Nicolas Huot; Jamila Elhmouzi-Younes; Cécile Lefebvre; Pierre Rosenbaum; Nathalie Dereuddre-Bosquet; Frédéric Martinon; Hakim Hocini; Antonio Cosma; Michaela Müller-Trutwin; Yves Lévy; Roger Le Grand; Anne-Sophie Beignon
Journal:  J Leukoc Biol       Date:  2019-02-22       Impact factor: 4.962

Review 4.  Redefining Memory: Building the Case for Adaptive NK Cells.

Authors:  Silke Paust; Catherine A Blish; R Keith Reeves
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 5.  Mouse and human FcR effector functions.

Authors:  Pierre Bruhns; Friederike Jönsson
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

Review 6.  Granulocytes: New Members of the Antigen-Presenting Cell Family.

Authors:  Ang Lin; Karin Loré
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

7.  Anti-inflammatory Trained Immunity Mediated by Helminth Products Attenuates the Induction of T Cell-Mediated Autoimmune Disease.

Authors:  Shauna M Quinn; Kyle Cunningham; Mathilde Raverdeau; Robert J Walsh; Lucy Curham; Anna Malara; Kingston H G Mills
Journal:  Front Immunol       Date:  2019-05-21       Impact factor: 7.561

8.  Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study.

Authors:  Simone J C F M Moorlag; Rosanne C van Deuren; Cornelis H van Werkhoven; Martin Jaeger; Priya Debisarun; Esther Taks; Vera P Mourits; Valerie A C M Koeken; L Charlotte J de Bree; Thijs Ten Doesschate; Maartje C Cleophas; Sanne Smeekens; Marije Oosting; Frank L van de Veerdonk; Leo A B Joosten; Jaap Ten Oever; Jos W M van der Meer; Nigel Curtis; Peter Aaby; Christine Stabell-Benn; Evangelos J Giamarellos-Bourboulis; Marc Bonten; Reinout van Crevel; Mihai G Netea
Journal:  Cell Rep Med       Date:  2020-08-05

Review 9.  Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development.

Authors:  Kathrin Balz; Lilith Trassl; Valerie Härtel; Philipp P Nelson; Chrysanthi Skevaki
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

10.  Trained Immunity Confers Broad-Spectrum Protection Against Bacterial Infections.

Authors:  Eleonora Ciarlo; Tytti Heinonen; Charlotte Théroude; Fatemeh Asgari; Didier Le Roy; Mihai G Netea; Thierry Roger
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

View more
  20 in total

1.  Oral Administration of a Shigella 2aT32-Based Vaccine Expressing UreB-HspA Fusion Antigen With and Without Parenteral rUreB-HspA Boost Confers Protection Against Helicobacter pylori in Mice Model.

Authors:  Xin Zhang; Shuli Sang; Qing Guan; Haoxia Tao; Yanchun Wang; Chunjie Liu
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

2.  Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC].

Authors:  Xuan Ying Poh; I Russel Lee; Clarissa Lim; Jefanie Teo; Suma Rao; Po Ying Chia; Sean W X Ong; Tau Hong Lee; Ray J H Lin; Lisa F P Ng; Ee Chee Ren; Raymond T P Lin; Lin-Fa Wang; Laurent Renia; David Chien Lye; Barnaby E Young
Journal:  Trials       Date:  2022-06-16       Impact factor: 2.728

Review 3.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

Review 4.  Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer's Disease - Inflammaging, Insulin Resistance, M. paratuberculosis and Immunosenescence.

Authors:  Coad Thomas Dow
Journal:  Front Immunol       Date:  2021-08-05       Impact factor: 7.561

5.  Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost.

Authors:  Amar K Garg; Soumya Mittal; Pranesh Padmanabhan; Rajat Desikan; Narendra M Dixit
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

Review 6.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01

Review 7.  Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine.

Authors:  Thuy Trang Nguyen; Trang Ho Thu Quach; Thanh Mai Tran; Huynh Ngoc Phuoc; Ha Thi Nguyen; Tuong Kha Vo; Giau Van Vo
Journal:  Biomed Pharmacother       Date:  2022-01-19       Impact factor: 6.529

8.  The Route of Vaccine Administration Determines Whether Blood Neutrophils Undergo Long-Term Phenotypic Modifications.

Authors:  Yanis Feraoun; Jean-Louis Palgen; Candie Joly; Nicolas Tchitchek; Ernesto Marcos-Lopez; Nathalie Dereuddre-Bosquet; Anne-Sophie Gallouet; Vanessa Contreras; Yves Lévy; Frédéric Martinon; Roger Le Grand; Anne-Sophie Beignon
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

9.  Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus.

Authors:  Suyeon Hong; Shaobo Ruan; Zachary Greenberg; Mei He; Jodi L McGill
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

10.  Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.

Authors:  Paul B Kilgore; Jian Sha; Emily K Hendrix; Vladimir L Motin; Ashok K Chopra
Journal:  mBio       Date:  2021-12-07       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.